Mavyret 20 mg/1

Mavyret is a combination medication containing glecaprevir and pibrentasvir, used for treating certain types of hepatitis C. This oral pellet formulation is designed for convenient administration.

Mavyret is primarily used in the treatment of chronic hepatitis C virus (HCV) infection. It is effective for various genotypes of HCV, offering a comprehensive solution for managing this condition. Patients often wonder, 'What is Mavyret used for?' and the answer lies in its ability to target and inhibit the virus, aiding in its eradication.

Common effects of Mavyret may include fatigue, headache, and nausea. Some individuals might experience changes in their bowel movements or mild gastrointestinal discomfort. These effects are generally temporary and vary among users.

Mavyret should be handled with care, ensuring it is stored properly to maintain its efficacy. It is important to follow the guidance of a healthcare provider regarding its use, especially for those with pre-existing liver conditions or other health concerns.

Mavyret may interact with certain medications, including those metabolized by the liver. It is advisable to consult a healthcare provider before combining Mavyret with other treatments, particularly those that affect liver function or are known to interact with antiviral drugs.